Clinical trial
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention…
NCT00441298 · Centre for the AIDS Programme of Research in South Africa, Other · Completed
Key facts
| NCT number | NCT00441298 |
|---|---|
| Title | Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV |
| Official title | Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa |
| Lead sponsor | Centre for the AIDS Programme of Research in South Africa, Other |
| Collaborators | FHI 360 United States Agency for International Development (USAID) U.S. Fed CONRAD |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir gel, Placebo (Universal HEC placebo) |
| Enrollment | 889 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Feb 28, 2007 |
| Last update posted | Feb 1, 2016 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: